KALEIBE THERAPEUTICS Trademark

Trademark Overview

On Wednesday, May 19, 2021, a trademark application was filed for KALEIBE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the KALEIBE THERAPEUTICS trademark a serial number of 90720336. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 4, 2023. This trademark is owned by Replay Holdings, LLC. The KALEIBE THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

scientific research and development; research and development in the pharmaceutical and biotechnology fields; research and development of technology in the field of gene therapy, genome writing, genome engineering, engineered HSV vector; testing, inspection, research, or development of pharmaceutical preparations for gene therapy
kaleibe therapeutics

General Information

Serial Number90720336
Word MarkKALEIBE THERAPEUTICS
Filing DateWednesday, May 19, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 4, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 8, 2022

Trademark Statements

Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and Servicesscientific research and development; research and development in the pharmaceutical and biotechnology fields; research and development of technology in the field of gene therapy, genome writing, genome engineering, engineered HSV vector; testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 17, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameREPLAY HOLDINGS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92121
Party NameReplay Holdings, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 92121
Party NameReplay Holdings, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 92130

Trademark Events

Event DateEvent Description
Monday, December 4, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 4, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 13, 2023SOU EXTENSION 2 GRANTED
Monday, March 13, 2023SOU EXTENSION 2 FILED
Monday, March 13, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, January 11, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, October 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 18, 2022SOU EXTENSION 1 GRANTED
Tuesday, October 18, 2022SOU EXTENSION 1 FILED
Tuesday, October 18, 2022SOU TEAS EXTENSION RECEIVED
Monday, June 13, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 13, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 13, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, May 20, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, May 20, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 20, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 20, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 20, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 3, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 8, 2022PUBLISHED FOR OPPOSITION
Wednesday, February 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 2, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 2, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, February 2, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, February 2, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, February 2, 2022EXAMINERS AMENDMENT -WRITTEN
Monday, January 31, 2022ASSIGNED TO EXAMINER
Tuesday, August 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 22, 2021NEW APPLICATION ENTERED

Related Keywords

therapeutics kaleibe development research genome therapy gene pharmaceutical engineered vector testing preparations